openPR Logo
Press release

Indian cancer monoclonal Antibodies Market Growth, Size, Share, Industry Report and Forecast to 2026

11-19-2020 06:50 AM CET | Health & Medicine

Press release from: Orion Market Research

Indian cancer monoclonal antibodies market is estimated to grow at a CAGR of 12.5% during the forecast period. Rising awareness regarding cancer is primarily encouraging market growth. Indian government programs to raise public awareness regarding cancer have been witnessed which is offering an opportunity for market growth. Cancer Awareness Campaign 2019 aims to create awareness regarding cancer amongst the Indian population. This intends to increase awareness regarding the importance of screening for early detection. The campaign named Raho cancer se do kadam aage, an initiative by the Indian Cancer Society. Additionally, the availability of some major entities providing affordable cancer treatment is further accelerating the demand for potential cancer therapies in the country.

A full Report of Indian cancer monoclonal Antibodies Market Available at

This includes Tata Memorial Hospital, Sri Shankara Cancer Hospital and Research Centre, Dharamshila Hospital and Research Centre (DHRC), and ICS Cancer Detection Centre, Mumbai. This, in turn, is driving the demand for monoclonal antibodies that serve as one of the established therapeutic strategies for both solid tumors and hematologic malignancies. It is a type of immunotherapy that stimulates the immune system of cancer patients and works to find and attack cancer cells. Increasing launches of cancer monoclonal antibody biosimilars are also providing scope for an increased access to cancer treatment in the country.

To learn more about this report request a free sample copy @

Scope of the Indian Cancer Monoclonal Antibodies Market

Market Coverage

• Market number available for 2019-2026
• Base year- 2019
• Forecast period- 2020-2026
• Segment Covered- By Type and Application
• Competitive Landscape- AstraZeneca plc, Biocon Ltd., F. Hoffman-La Roche AG, Cadila Pharmaceuticals Ltd., and Dr. Reddy’s Laboratories, Inc.

Recent Strategic Initiatives in the Indian Cancer Monoclonal Antibodies Market

• In July 2020, Ahmedabad-based Cadila Pharmaceuticals Ltd. declared the introduction of biosimilar Rituximab in India. It is indicated for the treatment of rheumatoid arthritis and blood cancer launched within the brand name Ritucad. It is used to treat Non-Hodgkin’s lymphoma (a type of blood-related cancer). According to the company, over 28,000 new cases of Lymphoma are reported each year in India. This launch will increase the accessibility of cancer treatment in the country.
• In August 2019, Dr. Reddy's Laboratories declared the launch of Versavo (bevacizumab). It is a biosimilar of Roche's Avastin in India, which is intended to treat multiple kinds of cancers (cervical cancer, metastatic breast cancer, recurrent glioblastoma, metastatic renal cell carcinoma, metastatic colorectal cancer, epithelial ovarian, non-squamous non-small cell lung cancer, fallopian tube, and primary peritoneal cancer.

Key questions addressed by the report

• What is the market growth rate?
• Which segment dominates the market in the base year?
• Which segment will project the fastest growth in the market?
• How COVID-19 impacted the market?
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Indian Cancer Monoclonal Antibodies Market-Segmentation

By Type

• Naked
• Conjugated
• Others (Bispecific)

By Application

• Breast Cancer
• Liver Cancer
• Blood Cancer
• Brain Cancer
• Colorectal Cancer
• Others

Company Profiles

• AstraZeneca plc
• Biocon Ltd.
• Cadila Pharmaceuticals Ltd.
• Dr. Reddy's Laboratories, Inc.
• F. Hoffmann-La Roche AG
• GlaxoSmithKline plc
• Intas Biopharmaceuticals Ltd.
• Lupin Ltd.
• Mylan N.V.
• Sun Pharmaceutical Industries Ltd.

For More Customized Data, Request for Report Customization

For More Information, Visit
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Contact no: +91 780-304-0404

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Indian cancer monoclonal Antibodies Market Growth, Size, Share, Industry Report and Forecast to 2026 here

News-ID: 2190262 • Views: 378

More Releases from Orion Market Research

Probiotics Supplement Market Trends, Business Overview, Industry Growth and Fore …
The global probiotics supplement market is anticipated to grow at a significant CAGR of 7.2% during the forecast period (2022-2028). The rising consumer awareness for healthcare and fitness with rising disposable income, are likely to drive the market growth. Probiotics enable to maintenance of a healthy balance of gut flora and have been linked to a variety of health advantages, including weight loss, digestive health, and immunological function. The market
Brick Pavers Market Top Leading Players with Strategies and Forecast 2028
Brick Pavers Market Size, Share & Trends Analysis is a professional and in-depth study on the current state of the global Brick Pavers market with a focus on the  market. The report provides key statistics on market of Brick Pavers. It is a valuable source of guidance and direction for companies and individuals interested in Brick Pavers industry. Key Players Belgard Acme Brick Company The Belden Brick Company Wienerberger Pine Hall Brick Redland Brick   By Type General Brick Pavers Wall
Global Famciclovir Market Top Leading Players with Strategies and Forecast 2028
The global famciclovir market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Famciclovir is used to herpes zoster generally called shingle (a rash that can occur in people who have had chickenpox in the past). It's also used to treat persons with a healthy immune system who have recurrent herpes virus cold sores or fever blisters. The herpes simplex virus causes cold sores. When this virus enters the
Global Performance Monitoring Module Market, Size, Share, Analysis Report & Fore …
The global performance monitoring module market is anticipated to grow at a significant CAGR during the forecast period. The adoption of wireless communication technology in machine condition monitoring, and deployment of automated condition monitoring, and the trend toward predictive maintenance of industrial machinery, are all major factors accelerating the growth of the global performance monitoring module market. Free Sample Copy @ Performance Monitoring Module (PMM) assists in identifying and resolving

All 5 Releases